Jean Hoffman

MedRhythms employs 40 people and has raised more than $60 million to date. It recently won FDA approval for a device to help Parkinson’s disease patients improve their walking, mobility and motor function.

Innovative firms in the growing niche range from big players like IDEXX and Covetrus to startups of more recent vintage, including Rarebreed Veterinary Partners and ElleVet Sciences.

MedRhythms has raised $37 million from angel investors, venture capital firms, Maine Technology Institute and private investors.